The higher expression of the co-stimulatory molecule and M1 marker CD40 on CD45/CD14+ cells in the 4-culture PANC-1 spheroids could explain the therapeutic effect of CD40 ligand/agonists in the treatment of PDAC, boosting an anti-tumor response (29, 30). This evidence concerns the gene PTPRC and neoplasm.